Good times for UK Life Science Surging energy prices, a cost-of-living crisis, looming stagflation and struggling stock markets: 2022’s financial headlines have seemed almost universally negative. Amidst all this gloom, it should notRead More

The modern Pharma industry has long had issues around “reputation” and much of the criticism has often centred on drug pricing. Commercial organisations developing and selling life changing and life-saving products are heldRead More

There is a growing agreement that the key issue facing the global drug industry over the coming years will be how to adapt to a digital landscape that is changing at an astonishingRead More